Funding profile · Health data infrastructure

Metriport

Two disclosed rounds, forty four months apart, and nothing on file with the SEC. The capital record here is what the company and the press have said, not what the company has filed.

$28.4MTotal raised to date, company-reported (Aug 2026)
$26.0MAnnounced Aug 27, 2026, led by Matrix
$2.4MSeed, Dec 2022, at a $20M valuation
0Form D notices on file with the SEC

Data as of September 23, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Jun 2022 Y Combinator, Summer 2022 batch Not disclosed Y Combinator YC data
Dec 2022 Seed, on post-money SAFEs $2.4M at a $20M valuation Y Combinator, Triple Impact Capital, Nueterra Capital, Leonis Investissement, Zillionize, VentureSouq, Stonks, MyAsiaVC, plus named angels TechCrunch
Aug 2026 Not named by stage in the release $26.0M Led by TJ Parker, general partner at Matrix; ARTIS; Y Combinator Company release
To date Cumulative $28.4M Matrix, ARTIS, Y Combinator named Company-stated

What the filings show

SEC EDGAR · no Form D on record · searched Sep 23, 2026

Company search
No matching companies for Metriport
Full text search
Zero documents mentioning Metriport, all form types
Form D notices
0
Seed instrument
Post-money SAFEs, per TechCrunch, Dec 2022
Latest round
$26,000,000 announced Aug 27, 2026, 27 days before this search
Related persons
None on record. No board composition disclosed
Filing
No CIK assigned

Reading the filings

  1. The paper trail is press, not filings.Every dollar attributed to Metriport comes from a TechCrunch story, a company blog post or an August 2026 press release. There is no Form D to check any of it against, and no CIK under which a future one would appear.
  2. That absence is lawful, and it is informative.An offering made under Regulation D requires a Form D within 15 days of the first sale. An issuer that instead relies on the Section 4(a)(2) private placement exemption files no notice at all. Both routes are legal; only one leaves a public record. Given a seed written entirely on post-money SAFEs, the second is the likelier explanation for the silence.
  3. The totals reconcile exactly.$2.4M plus $26.0M is $28.4M, the figure the company gives for money raised to date. The arithmetic leaves no room for an undisclosed priced round between December 2022 and August 2026, a gap of 44 months on a seed of $2.4 million.
  4. The step up is large and unpriced.The 2026 round is about 10.8 times the seed. The 2022 seed carried a stated $20 million valuation. The 2026 release carries none, and does not name a stage. One report notes the absence of both; other trade coverage the same day called it a Series A.
  5. No non-dilutive money appears.Searches of NIH RePORTER and NSF awards return nothing. Unlike device and diagnostics companies at this stage, Metriport has funded itself entirely on equity and network revenue.

Commercial signals

Signal Detail Source type
Network access Carequality implementer, with an implementer page dated Sep 12, 2023. CommonWell Service Adopter, listed Sep 23, 2026. Not on the Sequoia Project designated QHIN list. Public record
Permitted purpose Production access requires a covered entity, an NPI and a Treatment purpose of use. The sandbox requires none of them. Company-stated
Certification SOC 2 Type 2 and HIPAA per an archived security page. HITRUST r2 announced Aug 27, 2026. No independent listing found. Company-stated
Named customers Amazon One Medical, Sollis Health and Color Health in the funding release. The website adds Weight Watchers, Canvas Medical, Brightside Health, Cercanos Care and others. Company-stated
Public code AGPLv3 with an Enterprise Edition carve-out under the pkgs directory. 784 stars, 113 forks, 22 contributors. Synced in bursts, with no commits between Nov 2025 and Aug 2026. Public record
Team 29, per the Y Combinator profile. YC data
Litigation Reporting on Epic’s January 2026 complaint describes Metriport as the implementer that admitted, then removed, a company later named as a defendant. Metriport is not a defendant. Independent
Regulatory record No FDA clearances, registered trials, NIH awards, NSF awards or PubMed hits. Not found

What to watch

  • A first Form D. It would be due within 15 days of the first sale if the August 2026 offering relied on Regulation D.
  • Whether a valuation or a round name is ever attached to the $26 million.
  • Whether a priced round brings named directors, which a Form D would disclose.
  • Repository cadence as a proxy for the open source commitment the capital was raised on.
  • The Epic v Health Gorilla docket, which will test how implementers vet the organizations they list.

The Metriport story on Healthcare DiscoveryHealthcare Discovery

Related companies

Sources

  1. Public recordEDGAR company search and full text search for MetriportSEC · Sep 23, 2026
  2. Public recordmetriport/metriport repository, licence, contributors and commit historyGitHub · 2026
  3. Public recordCarequality implementer page for MetriportCarequality · Sep 12, 2023
  4. Public recordCommonWell members page, Service AdoptersCommonWell · 2026
  5. Public recordDesignated QHINsTEFCA RCE, The Sequoia Project · 2026
  6. IndependentHealthcare data is a mess and Metriport is here with a broomTechCrunch · Dec 21, 2022
  7. IndependentMetriport raises $26M to turn health-data access into clinical answersRuntimeWire · Aug 27, 2026
  8. IndependentMetriport Raises $26M to Scale Open-Source Clinical IntelligenceHIT Consultant · Aug 27, 2026
  9. IndependentEpic and health systems sue Health Gorilla and data companiesHealthcare IT News · Jan 13, 2026
  10. CompanyMetriport Raises $26 millionPR Newswire · Aug 27, 2026
  11. CompanyMetriport Raises $2.4M Seed RoundMetriport blog · Dec 21, 2022
  12. CompanyMedical API, Customers and About pagesmetriport.com · 2026

Compiled from SEC, Carequality, CommonWell, TEFCA RCE and GitHub public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; an issuer relying on Section 4(a)(2) files none. Healthcare Venture Capital Fund holds no position in Metriport. This page is not an offer to sell or a recommendation to buy any security.